Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Serologic Testing Helps Scientists Connect Dots on COVID-19 Clusters

By HospiMedica International staff writers
Posted on 01 May 2020
An epidemiological study has demonstrated how the use of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays helped established a link between two people with COVID-19 from Wuhan, China, and three clusters of COVID-19 cases in Singapore.

Linking disease transmission to an imported source and contact tracing for each identified case has facilitated a high capture of cases in Singapore. More...
Active case-finding and contact tracing were undertaken for all COVID-19 cases in the region. Diagnosis for acute disease was confirmed with RT-PCR testing. When epidemiological information suggested that people might have been nodes of disease transmission but had recovered from illness, SARS-CoV-2 IgG serology testing was used to establish past infection.

The epidemiological study shows how SARS-CoV-2 serological analysis (ELISA detecting IgG and VNT detecting neutralizing antibodies), in addition to the use of traditional epidemiological methods, was important in establishing links among locally transmitted COVID-19 cases and tracing the transmission chain to an imported source. Three clusters of COVID-19, comprising 28 locally transmitted cases, were identified in Singapore; these clusters were from two churches (Church A and Church B) and a family gathering. The clusters in Church A and Church B were linked by an individual from Church A (A2), who transmitted SARS-CoV-2 infection to the primary case from Church B (F1) at a family gathering they both attended on January 25, 2020. All cases were confirmed by RT-PCR testing because they had active disease, except for A2, who at the time of testing had recovered from their illness and tested negative. This individual was eventually diagnosed with past infection by serological testing. ELISA assays showed an optical density of more than 1·4 for SARS-CoV-2 nucleoprotein and receptor binding domain antigens in titres up to 1/400, and viral neutralization was noted in titres up to 1/320.

As shown in the study, serological testing enabled the detection of a convalescent case, which could be the key to initial containment efforts to discover transmission links to support containment efforts. Serological testing also detects people with mild or asymptomatic disease who have recovered, allowing for more accurate determination of the number of people probably infected in a cluster or the population. Identifying people who were probably infected in household or school clusters could help ascertain attack rates by age, particularly among children who mostly manifest less severe disease.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.